Zimmer Biomet recently announced entering a definitive agreement to acquire all outstanding common shares of Paragon 28. Under the agreement, Zimmer Biomet will pay $13.00 per share, valuing ...

Zimmer Biomet executives expect the company’s planned $1.1 billion acquisition of Paragon 28 to give the company a larger presence in the growing market for procedures at ambulatory surgery ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Get real-time ...

Shares of FNA opened at $13.03 on Wednesday. Paragon 28 has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a market capitalization of $1.09 billion, a P/E ratio of -17.60 and a ...

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst Price Forecast Suggests 12.46% Upside As of January 29, 2025 ...

Short interest in Paragon 28 Inc (NYSE:FNA) increased during the last reporting period, rising from 3.54M to 3.73M. This put 7.94% of the company's publicly available shares short. Short interest ...

Jan 28 (Reuters) - Zimmer Biomet (ZBH.N), opens new tab said on Tuesday it would acquire medical device company Paragon 28 (FNA.N), opens new tab for about $1.1 billion to expand its portfolio of ...

Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million.

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo.

Paragon 28, Inc. FNA shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.